Carlsmed
Transforming Spine Surgery Through Personalized Solutions
Carlsmed develops personalized spinal surgery technologies and procedures aimed at improving patient outcomes while reducing the cost of care. The company’s aprevo® platform combines patient-specific implants, 3D surgical planning and visualization, and data-driven workflows to deliver tailored spinal fusion solutions for lumbar and cervical indications. Carlsmed emphasizes clinical evidence, regulatory compliance and reimbursement support to accelerate adoption of personalized spine surgery.
Mission, Technology & Values
Our mission is to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. Core elements of our approach include:
- aprevo® Technology Platform: an end-to-end system for personalized spinal care including 3D planning, precision alignment, and optimized implant fit.
- myaprevo®: 3D visualization tools and patient-facing ecosystem to support personalized procedures.
- Clinical and Market Access: a focus on evidence generation and coding & reimbursement support to enable clinical adoption.
Carlsmed is patient-obsessed and guided by values of doing what is right and achieving together. The company is publicly traded (Nasdaq: CARL) and holds U.S. FDA clearances for its aprevo® devices for lumbar and cervical spinal fusion indications, with ongoing clinical programs and investor communications to support growth.